Becton, Dickinson Aktie
WKN: 857675 / ISIN: US0758871091
|
06.08.2026 12:54:47
|
Becton, Dickinson Boosts FY26 Adj. EPS Outlook - Update
(RTTNews) - While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for the full-year 2026, while maintaining annual revenue growth outlook.
For fiscal 2026, the company now projects adjusted earnings in a range of $12.62 to $12.72 per share, up from the prior forecast range of $12.52 to $12.72 per share.
The company continues to expect revenue growth in the low single-digit plus, with constant currency revenue growth in the low single-digit.
In Wednesday's pre-market trading, BDX is trading on the NYSE at $172.00, up $1.34 or 0.79 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Becton, Dickinson & Co. (BD)
Analysen zu Becton, Dickinson & Co. (BD)
Aktien in diesem Artikel
| Becton, Dickinson & Co. (BD) | 149,55 | 1,46% |
|